GINMU >

ブラウズ : 著者 3/0000231

発行日	タイトル	著者
2013年5月15日	Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness.	Yada, Koji; Nogami, Keiji; Ogiwara, Kenichi; Shima, Midori
2022年1月8日	Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry.	Ishikawa, Tomoaki; Nakajima, Yuto; Omae, Takashi; Ogiwara, Kenichi; Nogami, Keiji
2020年5月	Emicizumab improves the stability and structure of fibrin clot derived from factor VIII-deficient plasma, similar to the addition of factor VIII.	Shimonishi, Naruto; Nogami, Keiji; Ogiwara, Kenichi; Matsumoto, Tomoko; Nakazawa, Fumie; Soeda, Tetsuhiro; Hirata, Michinori; Arai, Nobuo; Shima, Midori
2019年1月	Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.	Minami, Hiroaki; Nogami, Keiji; Yada, Koji; Ogiwara, Kenichi; Furukawa, Shoko; Soeda, Tetsuhiro; Kitazawa, Takehisa; Shima, Midori
2019年4月	Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.	Furukawa, Shoko; Nogami, Keiji; Ogiwara, Kenichi; Shima, Midori
2022年7月	Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.	Hashimoto, Naoki; Ogiwara, Kenichi; Shimonishi, Naruto; Nakagawa, Takashi; Nakajima, Yuto; Furukawa, Shoko; Takeyama, Masahiro; Nogami, Keiji